Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Buprenorphine (or colloquially, "Bupe") is a semi-synthetic opiate with partial agonist and antagonist actions. Buprenorphine hydrochloride was first marketed in the 1980s by Reckitt & Colman (now Reckitt Benckiser) as an analgesic, available generally as Temgesic 0.2 mg sublingual tablets, and as Buprenex in a 0.3 mg/ml injectable formulation. In October 2002, the Food and Drug Administration (FDA) of the United States of America additionally approved Suboxone and Subutex, buprenorphine's high-dose sublingual pill preparations for opioid addiction, and as such the drug is now also used for this purpose. In the USA, it has been a Schedule III drug under the United Nations' Convention on Psychotropic Substances[1] since it was rescheduled from Schedule V (the schedule with the lowest restrictions and penalties in the USA) just before FDA approval of Suboxone and Subutex. In the recent years, buprenorphine has been introduced in most European countries as a transdermal formulation ("patc Group: Biochemicals. Grades: Purified. Pack Sizes: 500ul. US Biological Life Sciences.
Worldwide
Buprenorphine (BSA)
Buprenorphine (or colloquially, "Bupe") is a semi-synthetic opiate with partial agonist and antagonist actions. Buprenorphine hydrochloride was first marketed in the 1980s by Reckitt & Colman (now Reckitt Benckiser) as an analgesic, available generally as Temgesic 0.2mg sublingual tablets, and as Buprenex in a 0.3mg/ml injectable formulation. In October 2002, the Food and Drug Administration (FDA) of the United States of America additionally approved Suboxone and Subutex, buprenorphine's high-dose sublingual pill preparations for opioid addiction, and as such the drug is now also used for this purpose. In the USA, it has been a Schedule III drug under the United Nations' Convention on Psychotropic Substances since it was rescheduled from Schedule V (the schedule with the lowest restrictions and penalties in the USA) just before FDA approval of Suboxone and Subutex. In the recent years, buprenorphine has been introduced in most European countries as a transdermal formulation ("patch") f Group: Biochemicals. Pack Sizes: 1mg. US Biological Life Sciences.
Worldwide
Buprenorphine (BUP) (BSA)
Buprenorphine (or colloquially, "Bupe") is a semi-synthetic opiate with partial agonist and antagonist actions. Buprenorphine hydrochloride was first marketed in the 1980s by Reckitt & Colman (now Reckitt Benckiser) as an analgesic, available generally as Temgesic 0.2 mg sublingual tablets, and as Buprenex in a 0.3 mg/ml injectable formulation. In October 2002, the Food and Drug Administration (FDA) of the United States of America additionally approved Suboxone and Subutex, buprenorphine's high-dose sublingual pill preparations for opioid addiction, and as such the drug is now also used for this purpose. In the USA, it has been a Schedule III drug under the United Nations' Convention on Psychotropic Substances[1] since it was rescheduled from Schedule V (the schedule with the lowest restrictions and penalties in the USA) just before FDA approval of Suboxone and Subutex. In the recent years, buprenorphine has been introduced in most European countries as a transdermal formulation ("patc Group: Biochemicals. Grades: Purified. Pack Sizes: 500ug. US Biological Life Sciences.
A metabolite of Buprenorphine (B689570). Group: Biochemicals. Grades: Highly Purified. CAS No. 89663-73-0. Pack Sizes: 1mg, 2mg. Molecular Formula: C28H37NO3. US Biological Life Sciences.
Worldwide
Buprenorphine N-oxide
Buprenorphine N-oxide. Group: Biochemicals. Alternative Names: [5a,7a(S)]-17-(Cyclopropylmethyl)-a-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-a-methyl-6,14-ethenomorphinan-7-methanol 17-oxide. Grades: Highly Purified. CAS No. 112242-17-8. Pack Sizes: 1mg, 2mg, 5mg, 10mg. Molecular Formula: C29H41NO5. US Biological Life Sciences.
Worldwide
15,16-Didehydrobuprenorphine
15,16-Didehydrobuprenorphine is used in the synthetic preparation of [15,16-3H2]buprenorphine, which is a mixed agonist-antagonist opioid ligand. Group: Biochemicals. Grades: Highly Purified. CAS No. 61577-04-6. Pack Sizes: 500ug, 2.5mg. Molecular Formula: C29H39NO4. US Biological Life Sciences.
Worldwide
18,19-Dehydrobuprenorphine
An analogue of Buprenorphine (B689570) which displays high affinity and selectivity for μ-opioid receptors. It acts as an antinociceptive agent and potent analgesic. Group: Biochemicals. Grades: Highly Purified. CAS No. 155203-05-7. Pack Sizes: 250ug, 1mg. Molecular Formula: C29H39NO4. US Biological Life Sciences.